Testolone 15mg/tab 50 Tabletten by Rich Piana 5% Nutrition

Usage

1. Complete a full baseline bloodwork panel (LH, FSH, total testosterone, free testosterone, SHBG, ALT/AST) before taking the first tablet — this baseline is the reference point for measuring suppression depth at cycle end.
2. Take one 15 mg tablet once daily at a consistent time, preferably with a meal to support gastrointestinal tolerance; the blister strip makes it easy to confirm daily compliance at a glance.
3. At the midpoint of your cycle (approximately Week 4), rerun the LH and total testosterone panel — mid-cycle data reveals active suppression level and allows an informed decision about continuing, adjusting, or shortening the cycle.
4. Do not extend the cycle beyond eight weeks without re-evaluating bloodwork, as cumulative suppression depth increases non-linearly with duration and may shift the required recovery from a mini-PCT to a full SERM escalation protocol.
5. After the final tablet, observe a 72-hour washout window before drawing post-cycle blood — testing too early while active compound concentrations remain elevated will underestimate the true degree of HPTA suppression.
6. Use post-cycle bloodwork results to select the correct recovery tool: tamoxifen 20 mg/day or enclomiphene 12.5–25 mg/day for four weeks covers most moderate-suppression scenarios; consult endocrine data before escalating.

Warnings

Frequently asked questions

Do SARMs like RAD-140 actually suppress natural testosterone production?

Yes — RAD-140 suppresses endogenous testosterone by reducing LH and FSH output from the pituitary gland via hypothalamic feedback. Unlike non-suppressive compounds, RAD-140 activates the androgen receptor in a way that the hypothalamic-pituitary-testicular axis interprets as an androgen signal, resulting in measurable reductions in gonadotropin levels that have been documented in phase-I clinical trial data.

Which bloodwork markers should I test to assess RAD-140 suppression before starting a mini-PCT?

The minimum evidence-based panel includes serum LH, FSH, total testosterone, free testosterone, SHBG, and ALT/AST for liver safety. A baseline panel before the cycle is essential: without pre-cycle values, post-cycle results cannot be interpreted meaningfully. Blood should be drawn no sooner than 72 hours after the final RAD-140 tablet to avoid active-compound interference with the assay reading.

When is a mini-PCT enough after a RAD-140 cycle, and when should I use a full SERM-based recovery protocol?

A mini-PCT using 12.5–20 mg/day of tamoxifen citrate or enclomiphene for four weeks is generally adequate when cycle length was eight weeks or less, suppression is moderate, and post-cycle LH remains detectable above the laboratory reference lower limit. A full escalated SERM protocol is indicated when post-cycle total testosterone falls below approximately 300 ng/dL or when LH stays suppressed past the four-week mark of recovery.

Why does the 15 mg per tablet concentration of this product matter for cycle management?

At 15 mg per tablet, each unit corresponds exactly to the most commonly studied single daily research dose of RAD-140, eliminating the need to split tablets or combine partial doses. This simplifies both on-cycle tracking and the dose-reduction phases sometimes used in the final week of a cycle to ease suppression depth before PCT begins — a practical advantage over lower-dosed formats that require multi-tablet daily administration.

Are the tablets in this Rich Piana 5% Nutrition Testolone product packaged in blisters or a jar, and does the format affect dosing convenience?

The product is supplied in blister-pack format across a 50-tablet count, which supports per-dose precision and protects individual tablets from humidity and contamination between uses. Blister packaging also makes it straightforward to track daily intake and confirm no tablets have been missed — a detail that matters when precise dosing underpins the integrity of both the active cycle and the subsequent recovery protocol. (2) angle_used

Manufacturer

Rich Piana 5% Nutrition routes each batch of this Testolone product through a two-instrument verification sequence before release: first, HPLC (High-Performance Liquid Chromatography) chromatographic analysis — peak-area integration against a certified reference standard confirms that RAD-140 content per tablet falls within accepted tolerances of the 15 mg label claim; second, an LAL (Limulus Amebocyte Lysate) endotoxin screen, which detects bacterial endotoxin contamination at concentrations below the threshold of microbiological concern for research-grade materials. Neither test is treated as optional — both chromatographic and endotoxin data must pass specification before a batch proceeds to blister packaging and distribution. This instrument-first, release-second framework reflects the company's position that label accuracy and microbial safety are non-negotiable minimum standards for any compound in its research line.